Not it`s FAKE. There is very very strong resistance @340-350. And this level is looking after some months. Presently moementum looking flat & neutral. Only BUY if you can hold it for more than 1 year. Currently there is many chances to support partially. Partial Correction expected in next 15-20 days.

i am very bullish on BIOCON BUE TO THEIR PRODUCT CALLED IN101 ORAL INSULIN ie first world oral insulin this will take off pain of many patient

oral insulin will hit market in first quater of 2011 so in my view before 2011 it will go to 750 than may be more

Yeah abhay...i`m also very bullish on this stock... it would take a long time to give positive behaviou on the stock price but its a good hold in the portfolio

Dear you are looking dreams in a day. Very Good. Keep it up.

nothing possible with out dream and speculation time will teach me may be iam wrong

has a strong resistance at 400.

may take a few years to reach its lifetime high figure.

Resistance is a concern but it will move with market. In resistance is broken then new high will be seen.

Dr. Shastri,

Biocon was in in a range of 350 to 500 from Jan,`05 to June,`07 i.e a period of 2.5 years.

Technically it will take a somewhat similar pattern to breakout of this range.

Yes , it may easily double from cmp with 3/4 quarters of good results but 3 fold gains from here seems a bit far stretched as today also it is not cheap at a pe of 50 already.

I am holding this co for the last 4+ years and closely watching its performance.

Biocon has received 10 crs as Licensing Fee(LF) in Q2FY2010 from MYLAN. It adds Rs 2 EPS to the share. In the last conference call KMS has said, BIO will receive similar amount in the next 4 to 5 quarters. that means addition of Rs 8/- EPS to 5Rs share.
MYLAN wants BIO to mfg certain biosimilar drugs. KMS said confidently, they have the capability to make the drugs and also with in the time frame. MYLAN will sell them in US and other countries. BIO will get its profit on the quantities sold to MYLAN.

BIO has two drugs in Phase II, one CD6 for Arthritis and one T1h for Psoriasis. IN105 oral insulin in phase III for diabetics.
All the 3 drugs when marketed will be first time in the world, each with huge potential. The Mgt is confident of success of all the three drugs.

They have GCSF, BIOMAB100, BIOMAB200 in preclinical stage. BVX20 in phase II.

They are several other streams of profits for the co..

The company is in the take off stage.

Any body gets aboard, will have a profitable flight. I am myself buying as much as I can.

I will not be surprised if its price is Rs.1000 by this time next year

Please be advised mate: 10 Cr. will only mean 50p per share for the qrt and circa Rs2.00 per share on an annualised basis.

Price is a reflection of sentiments and I hope all goes well with IN105 by mid next year. Amen

mogembo khush hua, too many bees are flying

Yes You are correct. 100 crores is the capital and 20 crores shares of Rs.5/- each

Fundamentally u may be correct but technically seems difficult.

1:1 bonus last year. So the 500 of past means 250 where the share is today.